1. Dagher R, Helman L. Rhabdomyosarcoma: an overview. Oncologist. 1999; 4:34–44.
Article
2. Parham DM, Ellison DA. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med. 2006; 130:1454–65.
Article
4. Jaeckle KA. Neoplastic meningitis from systemic malignancies: diagnosis, prognosis and treatment. Semin Oncol. 2006; 33:312–23.
Article
5. Thiryayi SA, Rana DN, Roulson J, et al. Diagnosis of alveolar rhabdomyosarcoma in effusion cytology: a diagnostic pitfall. Cytopathology. 2010; 21:273–5.
Article
6. Thompson KS, Jensen JD, Bhoopalam N, Reyes CV. Pleural effusion cytology of embryonal rhabdomyosarcoma. Diagn Cytopathol. 1997; 16:270–3.
Article
7. Hamada T, Tanimoto A, Kaido M, Matsumoto S, Iribe K, Koide O. Diffuse pleural rhabdomyosarcoma with persistent pleural effusion. Acta Pathol Jpn. 1989; 39:803–9.
Article
8. Nelson AC, Singh C, Pambuccian SE. Cytological diagnosis of metastatic alveolar rhabdomyosarcoma in the ascitic fluid: report of a case highlighting the diagnostic difficulties. Cytojournal. 2012; 9:9.
Article
9. Bhattacharya B, Sariya D, Reddy VB, Kluskens L, Gould VE, Gattuso P. Application of adjunct techniques in cytologic material in the diagnosis of rhabdomyosarcoma: case report and review of the literature. Diagn Cytopathol. 2002; 26:384–6.
Article
10. Theunissen P, Cremers M, van der Meer S, Bot F, Bras J. Cytologic diagnosis of rhabdomyosarcoma in a child with a pleural effusion: a case report. Acta Cytol. 2004; 48:249–53.
11. Walts AE. Cerebrospinal fluid cytology: selected issues. Diagn Cytopathol. 1992; 8:394–408.
Article
12. Chamberlain MC, Glantz M, Groves MD, Wilson WH. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol. 2009; 36(4 Suppl 2):S35–45.
Article
13. Rudzinski ER, Teot LA, Anderson JR, et al. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Am J Clin Pathol. 2013; 140:82–90.
14. Dias P, Chen B, Dilday B, et al. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am J Pathol. 2000; 156:399–408.
Article
15. Atahan S, Aksu O, Ekinci C. Cytologic diagnosis and subtyping of rhabdomyosarcoma. Cytopathology. 1998; 9:389–97.
Article
16. van Gaal JC, Flucke UE, Roeffen MH, et al. Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications. J Clin Oncol. 2012; 30:308–15.
Article
17. Felkai L, Bánusz R, Kovalszky I, et al. The presence of ALK alterations and clinical relevance of crizotinib treatment in pediatric solid tumors. Pathol Oncol Res. 2017; Oct. 28. [Epub].
https://doi.org/10.1007/s12253-017-0332-1.
Article